v3.25.2
Condensed Consolidated Statements of Operations and Comprehensive Income (loss) (Unaudited)
€ in Thousands, $ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2025
EUR (€)
€ / shares
shares
Jun. 30, 2024
EUR (€)
€ / shares
shares
Jun. 30, 2025
EUR (€)
€ / shares
shares
Jun. 30, 2024
EUR (€)
€ / shares
shares
Revenue € 25 € 0 € 51 € 0
Cost of sales 19 0 39 0
Gross margin 6 0 12 0
Operating Expenses and Costs        
Selling and distribution expenses 244 193 474 243
General and administrative expenses 1,137 1,740 2,281 2,874
Research and development 525 336 968 557
Gain Loss on deconsolidation/reconsolidation 0 (756) 0 (63,491)
Other Operating income (128)   (132) (70)
Total Operating Expenses and Costs 1,778 1,431 3,591 (59,887)
(Loss)/Income from Operations (1,772) (1,431) (3,579) 59,887
Other Income (Expenses)        
Income from changes in fair value of convertible note payable carried at fair value 813 847 11,144 21,909
Gain (Loss) on foreign currency transactions 147 (859) 460 (2,357)
Total Other Income (Expense) 960 (12) 11,604 19,552
Net Income (Loss) € (812) € (1,443) € 8,025 € 79,439
Net income loss per share to common shareholders: (in dollars per share) | € / shares € (0.56) € (1) € 0.74 € 4.62
Basic (in EUR per Share) | € / shares € (0.56) € (1) € 5.53 € 54.82
Weighted average number of common shares: (in shares) | shares 1,449,921 1,449,293 10,874,054 17,194,420
Basic (in shares) | shares 1,449,921 1,449,293 1,449,919 1,449,094